Prelude Therapeutics Inc Quarterly Operating Lease, Right-of-Use Asset in USD from Q1 2021 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Prelude Therapeutics Inc quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q1 2021 to Q4 2024.
  • Prelude Therapeutics Inc Operating Lease, Right-of-Use Asset for the quarter ending December 31, 2024 was $28.7M, a 5.63% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2024 $28.7M -$1.71M -5.63% Dec 31, 2024 10-K 2025-03-10
Q3 2024 $29.2M +$28.7M +6189% Sep 30, 2024 10-Q 2024-11-06
Q2 2024 $29.6M +$28.7M +3122% Jun 30, 2024 10-Q 2024-08-12
Q1 2024 $30.1M +$28.7M +2114% Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $30.4M +$28.6M +1597% Dec 31, 2023 10-K 2025-03-10
Q3 2023 $464K -$890K -65.7% Sep 30, 2023 10-Q 2023-11-01
Q2 2023 $918K -$875K -48.8% Jun 30, 2023 10-Q 2023-08-03
Q1 2023 $1.36M -$864K -38.8% Mar 31, 2023 10-Q 2023-05-08
Q4 2022 $1.79M +$85K +4.98% Dec 31, 2022 10-K 2024-02-15
Q3 2022 $1.35M -$753K -35.7% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $1.79M -$104K -5.48% Jun 30, 2022 10-Q 2022-08-09
Q1 2022 $2.22M +$38K +1.74% Mar 31, 2022 10-Q 2022-05-10
Q4 2021 $1.71M Dec 31, 2021 10-K 2023-03-15
Q3 2021 $2.11M Sep 30, 2021 10-Q 2021-11-12
Q2 2021 $1.9M Jun 30, 2021 10-Q 2021-08-12
Q1 2021 $2.19M Mar 31, 2021 10-Q 2021-05-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.